---
title: "Fate Therapeutics (FATE) Gets a Buy from Mizuho Securities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290455976.md"
description: "In a report released today, from Mizuho Securities maintained a Buy rating on Fate Therapeutics, with a price target of $8.00.TipRanks' Prime Week Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Currently, the analyst consensus on Fate Therapeutics is a Moderate Buy with an average price target of $5.24."
datetime: "2026-06-22T15:15:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290455976.md)
  - [en](https://longbridge.com/en/news/290455976.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290455976.md)
generator: "portal-rs"
---

# Fate Therapeutics (FATE) Gets a Buy from Mizuho Securities

In a report released today, from Mizuho Securities maintained a Buy rating on Fate Therapeutics, with a price target of $8.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Currently, the analyst consensus on Fate Therapeutics is a Moderate Buy with an average price target of $5.24.

### Related Stocks

- [FATE.US](https://longbridge.com/en/quote/FATE.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)

## Related News & Research

- [Wedbush Reaffirms "Outperform" Rating for Fate Therapeutics (NASDAQ:FATE)](https://longbridge.com/en/news/295940831.md)
- [Dimensional Fund Advisors LP Lowers Stock Holdings in Fate Therapeutics, Inc. $FATE](https://longbridge.com/en/news/295994710.md)
- [Freeport-McMoRan (FCX): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/296794439.md)
- [Bernstein Keeps Their Buy Rating on DSV A/S (0JN9)](https://longbridge.com/en/news/296802697.md)
- [Cummins (CMI) Receives a Buy from CICC](https://longbridge.com/en/news/296811416.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**